Omeros (OMER) reported late Tuesday Q4 earnings of $0.98 per diluted share, swinging from a loss of $0.54 a year earlier.
Analysts expected a loss of $0.57 in a FactSet poll.
The biotechnology company also reported an adjusted EPS of $3.14 in the quarter.
Shares were up over 2% in after-hours trading.